About Dr. Nishtha Batra

Dr. Nishtha Batra is an experienced Oncopathologist in Bangalore with more than a decade of diagnostic expertise in pathology and cancer diagnostics across leading tertiary-care hospitals and oncology centres in India.

She currently serves as Head of the Histopathology Department at SPARSH Hospital, Hennur, Bengaluru, where she played a key role in establishing the histopathology department from its inception.

Dr. Nishtha Batra completed her MBBS from Government Stanley Medical College, Chennai, followed by an MD in Pathology from Mysore Medical College and Research Institute, Mysore.

She later pursued advanced superspeciality training and completed her DM in Oncopathology from Tata Memorial Hospital, Mumbai, one of India's leading centres for cancer diagnosis, treatment and research.

Her clinical diagnostic expertise includes oncopathology, surgical pathology, cytopathology and molecular diagnostics, with a strong focus on accurate tumour classification and pathology-based cancer diagnosis.

Dr. Nishtha Batra has a special interest in breast neoplasms, gastrointestinal tumours, bone and soft tissue tumours, haematolymphoid neoplasms and gynaecological cancers.

Her work involves detailed microscopic and molecular assessment of tissue and cellular samples to support accurate cancer diagnosis, tumour classification, staging and multidisciplinary treatment planning.

She has extensive experience in breast pathology, including the evaluation of benign, pre-malignant and malignant breast lesions and the interpretation of pathology findings that guide oncology treatment decisions.

Her expertise also extends to gastrointestinal pathology and gynaecological neoplasms, where accurate histopathological diagnosis is essential for determining tumour type and helping multidisciplinary cancer teams plan appropriate treatment.

Dr. Nishtha Batra is actively involved in academic research and has contributed to peer-reviewed publications involving uterine tumours, salivary gland tumours, neuroendocrine malignancies and other uncommon cancer presentations.

She also serves as a peer reviewer for the Indian Journal of Gynecologic Oncology and remains involved in teaching and academic activities in oncopathology.

Her approach emphasises accurate, evidence-based and clinically relevant pathology reporting to support personalised and multidisciplinary cancer care.

Oncopathology Evaluation

Specialised microscopic and diagnostic assessment of tissue samples to identify malignant and pre-malignant conditions and provide pathology information required for cancer treatment planning.

Cancer Biopsy Evaluation

Detailed examination of biopsy specimens to determine whether abnormal tissue is benign, pre-cancerous or malignant and to characterise the tumour when cancer is detected.

Histopathology Diagnosis

Microscopic evaluation of tissue specimens to identify disease patterns, classify tumours and provide definitive pathological diagnoses for a wide range of medical conditions.

Surgical Pathology

Examination of tissues removed during surgical procedures to establish diagnosis, evaluate tumour characteristics and provide information relevant to further clinical management.

Cytopathology

Diagnostic examination of individual cells and small cellular samples to detect cancers, pre-cancerous changes and other abnormalities.

Breast Tumour Pathology

Specialised pathological evaluation of breast biopsies and surgical specimens to classify breast lesions and provide clinically important information for cancer treatment planning.

Bone and Soft Tissue Tumour Pathology

Detailed pathological assessment of bone and soft tissue lesions to differentiate benign conditions from sarcomas and other malignant tumours.

Gastrointestinal Cancer Pathology

Microscopic evaluation of tumours involving the stomach, intestines, colon, rectum and other gastrointestinal organs to support accurate diagnosis and classification.

Gynaecological Cancer Pathology

Specialised diagnostic evaluation of tumours involving the uterus, cervix, ovaries, vulva and other gynaecological organs.

Hematolymphoid Neoplasm Diagnosis

Pathological assessment of lymphoid and haematological malignancies using morphology and additional diagnostic techniques to assist in accurate disease classification.

Molecular Cancer Diagnostics

Use of molecular testing to identify specific genetic or molecular alterations in tumours that can support diagnosis, prognosis and personalised oncology treatment decisions.

Tumour Classification and Grading

Detailed pathological classification and grading of tumours based on microscopic characteristics to provide important information about tumour behaviour and clinical management.

Cancer Pathology Review

Specialist review of pathology slides and diagnostic material for complex or uncommon tumours where additional oncopathology expertise may help confirm or refine the diagnosis.